Side-by-side comparison

ABBV vs AMGN — Side-by-side comparison

ABBV screens cheaper on EV/FCF, AMGN has the higher ROIC, AMGN has grown revenue faster over five years, and AMGN has the cleaner balance sheet by net debt / EBITDA.

ABBV

AbbVie Inc.

Price

$215.70

Market cap

$346.8B

Day %

N/A

AMGN

Amgen

Price

$339.30

Market cap

$150.6B

Day %

N/A

Peer Comparison

Target stock against 1 market-cap comparable peer.

Heat map: red worst to green best


ABBV Target	AbbVie Inc.	$346.8B	91.4x	22.8x	6.9%	6.0%	29.1%	N/A	3.7x	N/A
AMGN	Amgen	$150.6B	23.8x	24.2x	12.2%	7.6%	22.0%	N/A	3.2x	N/A

ABBV implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

22.8x

FCF yield

5.1%

5Y rev CAGR

6.0%

AMGN implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

24.2x

FCF yield

5.4%

5Y rev CAGR

7.6%

5Y indexed stock chart

Static Recharts view indexed to 100 from available annual per-share data.

Quality Scorecard

Build-time composite score for ABBV.

Grade C

/ 100

Quality Scorecard

Build-time composite score for AMGN.

Grade C

/ 100